Wednesday, October 24, 2012

JSGCL - JS Global Capital Limited - Analysis - 24/10/2012

Company JSGCL Symbol
Company Name JS Global Capital Limited Company Name
Avg EPS Rs 9.10 Average of past year end EPS's
Avg EPS FV Rs 91.00 Fair Value based on average of past year end EPS's
EPS Rs 4.17 Last four quarters EPS
EPS FV Rs 41.70 Fair Value based on last four quarters EPS
Current Price Rs 31.00 Last closing stock price
Div Rs 3.50 Total dividend paid during last four quarters
Div FV Rs 35.00 Fair value based on total dividend paid during last four quarters
Avg Div Rs 5.00 Average of yearly dividends paid (including currently paid ones)
Avg Div FV Rs 50.00 Fair value based on Average of yearly dividends paid (including currently paid ones)
Avg Rs 37.59 Average of Avg EPS FV, Book Value, Div FV, Avg EPS FV, Avg Div FV, Net Current Asset Value / Share and FV CF/S.
Upside 21.25% Upside potential (in percentage) based on the above Average.
Div Yield 11.29% Dividend yield
Book Value Rs 53.60 Book Value
Sector Financial Services Sector
FV CF/S Rs -55.54 Fair Value based on cash flow per share
Outstanding Shares 50,000,000 Number of  Outstanding Shares
Current Assets Rs 2,778.00 Currency in Millions of Pakistan Rupees
Total Liabilities Rs 410.90 Currency in Millions of Pakistan Rupees
NCAV/S Rs 47.34 Net Current Asset Value / Share
Total Assets Rs 3,091.10 Currency in Millions of Pakistan Rupees
Quarter June 2012 Data Quarter
CfO Rs -277.70 CASH FROM OPERATIONS (Millions of Rs)
CF/S Rs -5.55 Cash Flow per Share

Yes, this company is worth having a look into. Look at the price performance below. Its already gone up from Rs 16.70 to Rs 31.00 and still has room (21.25%) till it hits Rs 37.59, which is where I would put its real value.

Symbol JSGCL
Current Price Rs 31.00
Previous Day Price Rs 30.90
Daily Return 0.32%
Price Week Ago Rs 28.50
Weekly Return 8.77%
Price Month Ago Rs 29.16
Monthly Return 6.31%
Price Quarter Ago Rs 31.95
Quarterly Return -2.97%
Price Year Ago Rs 16.70
Yearly Return 85.63%



Share/Bookmark

No comments:

Post a Comment